Fungal cell wall glucan (BDG) (BDG)

Fungal cell wall glucans are critical structural polysaccharides, primarily composed of (1,3)-beta-D-glucan and (1,6)-beta-D-glucan, that maintain the mechanical strength and osmotic integrity of the fungal cell wall (Source: NCBI Bookshelf, "The Fungal Cell Wall"). These molecules are essential for fungal growth and survival but are notably absent in human cells, providing a high degree of selectivity for therapeutic intervention (Source: PubMed, PMID: 16120217). In clinical medicine, (1,3)-beta-D-glucan serves as a vital biomarker for the early diagnosis of invasive fungal infections, such as candidiasis and aspergillosis, through specialized serum assays (Source: CDC, "Laboratory Diagnosis of Invasive Fungal Infections"). Therapeutic agents like echinocandins (e.g., caspofungin) and the triterpenoid ibrexafungerp exert their antifungal effects by inhibiting the enzyme (1,3)-beta-D-glucan synthase, thereby preventing the polymerization of these glucans (Source: StatPearls, "Echinocandins"). This depletion leads to a weakened cell wall, making the fungus susceptible to osmotic lysis and immune clearance. Furthermore, these glucans act as pathogen-associated molecular patterns (PAMPs) that are recognized by host immune receptors, such as Dectin-1, to trigger an inflammatory response (Source: Nature Reviews Immunology, "Dectin-1 and its role in antifungal immunity").

Other names

(1,3)-beta-D-glucan(1,6)-beta-D-glucanBeta-glucanFungal glucanCell wall beta-glucan

Inhibition of (1,3)-beta-D-glucan synthase, leading to the depletion of glucan polymers in the fungal cell wall, resulting in osmotic instability and cell lysis.